Our VisionBoard Of DirectorsManagement

About Us

Our Vision

We believe that diagnostics can be made smarter, better, and faster. We are building a diagnostic technology that can be used at the point of care to identify multiple pathogens simultaneously. This will empower clinicians and provide vulnerable patients the immediate reassurance that they deserve and expect. Furthermore, we will create a network in which repeated testing of patients at the point of care builds up a digital map of pathogens that could be used to track outbreaks of disease, and make prescribing personal and targeted.

The Board

Mr. Dade Wang


Nearly 30 years of rich and successful experience in enterprise management and investment. His group owns a number of shareholding and holding companies encompassing construction, estate development, hotel intelligence, biomedicine, laser technology, mineral resources, high-tech R&D and applications and beyond.

Professor Tao Wang

Founder & Director

Senior Lecturer, Faculty of Medical & Human Sciences at The University of Manchester. Over 25 years’ experience in biomedical research on molecular and cell biology including 11 years’ postdoc experience Cambridge.

Dr James Zhang

Founder & Director, Acting General Manager

Qualified medical doctor over 30 years. Received PhD degree on clinical pharmacology and molecular biology at the University of Cambridge. Chairman of the Society for professional Talent Development (SPTD), and Chairman of Overseas Chinese Society for Technology & Business in UK (OCSTB). Board member of World Association of Chinese Doctors.

Professor Lin Li

Founder & Director

Laser Processing Research at University of Manchester, President of Laser Institute of America in 2016. He has over 560 publications in peer-reviewed journals and conferences. He holds 47 patents in optical engineering and was awarded the Sir Frank Whittle Medal from the Royal Academy of Engineering in 2013 for outstanding achievements.

Ms. Jing Sun


Ten year experience in the field of investment, participated in many investment projects that involve estate development, hotel intelligence, biomedicine, laser technology and other fields. She has experience in the whole process of investment management from investment analysis to post-investment management.


George Goh

Chief Technology Officer (CTO)

Specialist in industrial biotechnology, medical engineering, laser processing and 3D printing, plays a leading technical role on R&D focused projects. He obtained MSc on industrial biotechnology, and PhD in tissue engineering. Previously worked at the Aimen Laser Application Centre in Spain and was involved in the SP7 FabiMed and FaiERA projects for the development of cost effective medical devices.